Literature DB >> 26305624

The rural-urban effect on spatial genetic structure of type II Toxoplasma gondii strains involved in human congenital toxoplasmosis, France, 2002-2009.

Daniel Ajzenberg1, Frédéric Collinet2, Dominique Aubert3, Isabelle Villena3, Marie-Laure Dardé4, Sébastien Devillard5.   

Abstract

Congenital toxoplasmosis involves Toxoplasma gondii type II strains in 95% of cases in France. We used spatial principal component analysis (sPCA) and 15 microsatellite markers to investigate the spatial genetic structure of type II strains involved in 240 cases of congenital toxoplasmosis in France from 2002 through 2009. Mailing addresses of patients were geo-referenced a posteriori in decimal degrees and categorized into urban or rural areas of residence. No spatial genetic structure was found for type II strains that infected mothers who were living in urban areas, but a global spatial genetic structure was found for those that infected mothers who were living in a rural environment. Our results suggest that sources of infection by T. gondii are different in rural and urban areas in France, and advocate for targeted messages in the prevention of toxoplasmosis according to the type of residence of susceptible people.
Copyright © 2015 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Congenital toxoplasmosis; Microsatellite markers; Rural; Spatial genetic structure; Spatial principal component analysis; Urban

Mesh:

Year:  2015        PMID: 26305624     DOI: 10.1016/j.meegid.2015.08.025

Source DB:  PubMed          Journal:  Infect Genet Evol        ISSN: 1567-1348            Impact factor:   3.342


  6 in total

1.  Toxoplasma gondii in the faeces of wild felids from the Atlantic Forest, Brazil.

Authors:  Paula F Bolais; Lokman Galal; Cecília Cronemberger; Fabiane de Aguiar Pereira; Alynne da Silva Barbosa; Laís Verdan Dib; Maria Regina Reis Amendoeira; Marie-Laure Dardé; Aurélien Mercier
Journal:  Mem Inst Oswaldo Cruz       Date:  2022-06-27       Impact factor: 2.747

2.  Environmental risk factors for Toxoplasma gondii infections and the impact of latent infections on allostatic load in residents of Central North Carolina.

Authors:  Andrey I Egorov; Reagan Converse; Shannon M Griffin; Jennifer Styles; Elizabeth Klein; Elizabeth Sams; Edward Hudgens; Timothy J Wade
Journal:  BMC Infect Dis       Date:  2018-08-23       Impact factor: 3.090

3.  The introduction of new hosts with human trade shapes the extant distribution of Toxoplasma gondii lineages.

Authors:  Lokman Galal; Amedine Sarr; Thomas Cuny; Carine Brouat; Fatoumata Coulibaly; Mbacké Sembène; Moustapha Diagne; Mamoudou Diallo; Aliou Sow; Azra Hamidović; Nicolas Plault; Marie-Laure Dardé; Daniel Ajzenberg; Aurélien Mercier
Journal:  PLoS Negl Trop Dis       Date:  2019-07-11

4.  First isolation and molecular characterization of Toxoplasma gondii strains from human congenital toxoplasmosis cases in Monastir, Tunisia.

Authors:  Ibtissem Lahmar; Arwa Lachkhem; Oussama Babba; Darine Slama; Aida Trabelsi; Karine Passebosc-Faure; Marie Laure Dardé; Hamouda Babba
Journal:  Sci Rep       Date:  2020-02-06       Impact factor: 4.379

Review 5.  Toxoplasma gondii Genotyping: A Closer Look Into Europe.

Authors:  Mercedes Fernández-Escobar; Gereon Schares; Pavlo Maksimov; Maike Joeres; Luis Miguel Ortega-Mora; Rafael Calero-Bernal
Journal:  Front Cell Infect Microbiol       Date:  2022-03-23       Impact factor: 5.293

6.  Toxoplasmosis in patients with an autoimmune disease and immunosuppressive agents: A multicenter study and literature review.

Authors:  Marie-Fleur Durieux; Jean-Guillaume Lopez; Maher Banjari; Karine Passebosc-Faure; Marie-Pierre Brenier-Pinchart; Luc Paris; Gilles Gargala; Sabine Berthier; Julie Bonhomme; Cathy Chemla; Isabelle Villena; Pierre Flori; Emilie Fréalle; Coralie L'Ollivier; Florian Lussac-Sorton; José Gilberto Montoya; Estelle Cateau; Christelle Pomares; Loïc Simon; Dorothée Quinio; Florence Robert-Gangneux; Hélène Yera; Marc Labriffe; Anne-Laure Fauchais; Marie-Laure Dardé
Journal:  PLoS Negl Trop Dis       Date:  2022-08-08
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.